KDR and neoplasm: Another concept transducing T cells to co-express both an anti-VEGFR-2 CAR and inducible IL-12 augmented the tumor clearance in multiple in vivo models by targeting tumor vasculature as well as decreasing VEGFR-2-expressing MDSC subsets [99].